Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Budd-Chiari syndrome secondary prevention
Introduction
Overview
Overview
Secondary prevention strategies following Budd-Chiari syndrome include various measures such as, initiation of anticoagulation immediately in patients to prevent propagation of the clot, provided there are no contraindications. Effective management of esophageal varices. Patients with Budd-Chiari syndrome treated with balloon dilatation or stents require follow-up catheterizations and repeat dilatations or stent replacement. All patients should have routine surveillance for hepatocellular carcinoma (HCC).
Secondary Prevention
Secondary Prevention
Secondary prevention strategies following Budd-Chiari syndrome include: [1][2]
- Anticoagulation should be initiated immediately in patients to prevent propagation of the clot, provided there are no contraindications.
- Effective management of esophageal varices.
- Patients with Budd-Chiari syndrome treated with balloon dilatation or stents require follow-up catheterizations and repeat dilatations or stent replacement.
- All patients should have routine surveillance for hepatocellular carcinoma (HCC).
References
References
- ↑ Goel RM, Johnston EL, Patel KV, Wong T (2015). “Budd-Chiari syndrome: investigation, treatment and outcomes”. Postgrad Med J. 91 (1082): 692–7. doi:10.1136/postgradmedj-2015-133402. PMID 26494427.
- ↑ Ren W, Qi X, Yang Z, Han G, Fan D (2013). “Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review”. Eur J Gastroenterol Hepatol. 25 (7): 830–41. doi:10.1097/MEG.0b013e32835eb8d4. PMID 23411869.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]